Outpatient fractionated ICE protocol in relapsed/refractory lymphomas: Efficacy and safety.
Reyad DadaEhab Mosaad AbdelghaniTarek BoubakraJaweed VayaniOsama YousofEmily L Goldman HeaphyAzhar NawazPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Our study included, to our knowledge, the largest number of patients treated with outpatient fractionated ICE. Results demonstrated that this regimen might be a reasonable replacement for classic ICE regimen in many patients with lymphoma. It has a favorable safety profile. However, patients with primary refractory lymphomas need more effective regimens.